Eu-Gene Cheah is an equity investment analyst at Capital Group, with research responsibility for the pharmaceutical and biotechnology sectors in Europe and Japan, and health care companies in Australia. He has 18 years of investment experience, all with Capital Group. Before joining Capital, Eu-Gene was a doctor in the U.K., where he was a Member of the Royal College of Physicians and a Fellow of the Royal College of Ophthalmologists. He holds an MBA with distinction from INSEAD, France, as well as a degree in clinical medicine from Oxford University, where he was a Rhodes scholar. Eu-Gene is based in Singapore.
Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.
Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses or the collective investment trust's Characteristics statement, which can be obtained from a financial professional, Capital or your relationship manager, and should be read carefully before investing.
Securities offered through American Funds Distributors, Inc.
Content contained herein is not intended to serve as impartial investment or fiduciary advice. The content has been developed by Capital Group, which receives fees for managing, distributing and/or servicing its investments.